Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

University of Rochester, Neuromuscular Disease Center, Rochester

Johns Hopkins Hospital, Baltimore

Ohio State University Medical Center, Columbus

University of Minnesota, Minneapolis

Washington University Medical School, St Louis

University of Kansas Medical Center, Kansas City

University of Texas Health Science Center, San Antonio

University of Utah, Salt Lake City

University of California Irvine Medical Center; MDA, ALS and Neuromuscular Center, Orange

University of California, Davis, Sacramento

Oregan Health and Science University, Portland

Universit of Texas Medical Branch, Galveston